| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db2968ea930da6f8b6e0355bdc299761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_717c792fca7cc9c290c9db33e8fe078b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate |
2004-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b01681512aa6c890c3e12c9218acc8f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c08a2a6bc50d3fb171293ee63472fb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5eb7821755b0d130957dbffd073ff14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4bf33f91f647c141b89388e803d3ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7116187b3f8ae5618e19beee0da8fd26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa65c82559c70256d532e0d86efe1c7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ec94836fc9610f2c36d29575d995f62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e9c5a37cf3d02bc04c4e2318ac08fa |
| publicationDate |
2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100482379-B1 |
| titleOfInvention |
Novel microorganism capable of metabolizing isoflavone |
| abstract |
Provided is a microorganism capable of metabolizing isoflavones. The isoflavone metabolites has improved estrogen effect. Therefore, isoflavone metabolites are useful for prevention and treatment of osteoporosis, and are useful as antioxidant, anticancer and antimutation agent. The microorganism capable of metabolizing isoflavones is SNU-NiuO16(KCCM-10491), wherein the microorganism SNU-NiuO16(KCCM-10491) is isolated from the stomach of cow; the isoflavones are daidzein and genistein; and the isoflavone metabolites are dihydrodaidzein and dihydrogenistein. The method for producing the isoflavone metabolites comprises inoculating the microorganism SNU-NiuO16(KCCM-10491) into BHI medium and culturing the microorganism under anaerobic condition consisting of 5-10% CO2, 5-15% H2 and 75-90% N2; and the initial pH of the medium is 6.0-8.0 and final concentration of isoflavone in the medium is 400-8900 microM. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108982685-A |
| priorityDate |
2004-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |